Archives
-
Selonsertib (GS-4997) for Stress-Pathway Assays
2026-09-21
Selonsertib (GS-4997) enables selective ASK1 pathway interrogation in oxidative stress, inflammation, fibrosis, and metabolic disease models. This article develops an assay-design framework connecting ASK1 signaling with the Galectin-1–FIP200 autophagy axis without overstating evidence from hepatic steatosis studies.
-
8-DY547-cGMP for CA2 Signaling Assays
2026-09-21
8-DY547-cGMP offers a fluorescence-based route for investigating cyclic GMP biology alongside hippocampal perineuronal-net studies. This article explains how to use the reagent as an orthogonal assay tool without confusing cGMP measurements with direct evidence of Alzheimer’s disease pathology.
-
Vorinostat: HDAC Inhibition in Cancer Research
2026-09-20
Vorinostat, also called suberoylanilide hydroxamic acid, is an HDAC inhibitor that increases histone acetylation and changes transcriptional programs. Its research value spans epigenetic modulation in oncology, apoptosis assays, and cutaneous T-cell lymphoma models, but biochemical potency and cell-growth IC50 values are assay-dependent.
-
NMDA: From Excitotoxicity to Ferroptosis Assays
2026-09-19
Explore how NMDA (N-Methyl-D-aspartic acid) connects receptor-driven excitotoxicity with oxidative stress and ferroptosis measurements. This article translates a retinal ganglion cell study into practical assay-design guidance for mechanistic neuroscience research.
-
Dyngo-4a: A Practical Dynamin Inhibitor Guide
2026-09-18
Dyngo-4a is a research-grade dynamin inhibitor for testing vesicle scission, clathrin-dependent uptake, and cargo trafficking. This guide translates its mechanism into practical dose-response, imaging, neuronal, and lipid nanoparticle mRNA assay workflows while separating established evidence from experimental extensions.
-
Moxidectin Potentiates Polyenes Against Oral Candidiasis
2026-09-18
A 2024 study found that Moxidectin enhances amphotericin B and nystatin activity against Candida albicans by increasing fungal ergosterol biosynthesis and polyene binding. The combination reduced fungal burden and tongue inflammation in a mouse oral candidiasis model, supporting moxidectin as an experimental polyene potentiator rather than an established antifungal therapy.
-
TAI-1: Hec1 Inhibition from Cell Origin to Assay
2026-09-17
TAI-1 is a potent Hec1 inhibitor whose mitotic mechanism can be studied more rigorously when cell state, RB1 biology, and assay design are considered together. This article connects TAI-1 pharmacology with new retinal organoid evidence while defining practical boundaries for cancer research interpretation.
-
Antiseptics for Burns: Evidence, Methods, and Gaps
2026-09-17
The 2017 Cochrane review of antiseptics for burns examined whether topical antiseptic and antibiotic approaches improve healing, prevent infection, or reduce treatment-related harm. Its main contribution was a structured comparison of clinically important outcomes across heterogeneous studies, showing why differences in dressings, patient populations, and outcome definitions limit confident conclusions.
-
Tropifexor (LJN452) for Reliable FXR Assays
2026-09-16
A scenario-based guide to using Tropifexor (LJN452), SKU BA3602, in FXR, viability, proliferation, and intestinal barrier experiments. It explains concentration planning, DMSO controls, interpretation limits, and practical criteria for selecting a research-grade small molecule.
-
NMDA for Excitotoxicity and RGC Research
2026-09-16
Use NMDA to create a controlled receptor-mediated injury stimulus for excitotoxicity research, calcium influx measurement, and oxidative stress assay development. A workflow built around fresh dosing, temporal sampling, and BMP4-GPX4 pathway readouts can connect neuronal injury phenotypes with retinal stem-cell and glaucoma model questions.
-
Intestinal Stretch, Obesity, and Weight-Loss Recovery
2026-09-15
This study shows that intestinal stretch acutely suppresses feeding and improves oral glucose tolerance through mechanisms that do not require classical GLP-1 signaling. Obesity weakens this gut–brain response, whereas dietary and surgical weight loss restore intestinal stretch-induced satiety and enhance neuronal activation in the nucleus of the solitary tract.
-
Mutant p53-R280K Rewires FASN-Driven Lipogenesis
2026-09-15
A 2026 Molecular Biology Reports study identifies a gain-of-function mechanism in which mutant p53-R280K co-opts SREBP1 to activate FASN transcription, increase de novo fatty acid synthesis, and promote breast cancer progression. The work connects a specific TP53 mutation to lipid metabolic reprogramming and shows that both genetic and pharmacological FASN inhibition can suppress the resulting malignant phenotypes.
-
Q-VD(OMe)-OPh in Mechanism-Resolved Cell Death Assays
2026-09-14
Q-VD(OMe)-OPh enables causal caspase inhibition in apoptosis research rather than relying on viability measurements alone. This guide explains how to use it to distinguish apoptosis from ferroptosis and autophagy in resistant colorectal cancer models, while defining translational limits.
-
ATS-9R: Precision Gene Delivery for Adipose Research
2026-09-14
ATS-9R, or Adipocyte-targeting sequence-9-arginine, connects Prohibitin-directed tissue recognition with nona-arginine-mediated nucleic acid delivery. This evidence-led article explains the biology, validation strategy, practical parameters, competitive positioning, and translational limits that matter when designing adipose-targeted gene-silencing studies.
-
Cy5 Tyramide Signal Amplification Kit
2026-09-13
The Cy5 TSA Fluorescence System Kit connects high-sensitivity imaging with biologically informed assay design. Learn how its HRP-driven deposition chemistry can clarify low-abundance signaling, including the p53-R280K/SREBP1/FASN axis in breast cancer research.